CapsoVision has appointed gastroenterologist David S. Shields, M.D., to its Board of Directors, effective July 1, 2026. Dr. Shields brings over 40 years of experience in academic medicine, clinical gastroenterology, and advanced endoscopy, and has served as a clinical advisor to the company for nearly a decade. He succeeds Joanne C. Imperial, M.D., who will continue supporting CapsoVision as an independent clinical consultant. The appointment comes as the company approaches milestones including the anticipated commercial launch of an AI-assisted reading feature for its CapsoCam Plus capsule endoscope, continued development of its second-generation CapsoCam Colon program, and expansion of its broader capsule platform. Dr. Shields has maintained a private gastroenterology practice in Palo Alto since 1986, previously served as Assistant Professor of Medicine at Stanford University School of Medicine and Director of Endoscopy at Stanford Hospital, and has nearly two decades of experience using capsule endoscopy for small bowel disorders and gastrointestinal bleeding.
CapsoVision, Inc. Common StockAppointment of experienced gastroenterologist to board supports upcoming AI-assisted reading feature launch and capsule platform expansion.